NO883444L - Fremgangsmaate til fremstilling av nye, umettede aminosyreforbindelser. - Google Patents

Fremgangsmaate til fremstilling av nye, umettede aminosyreforbindelser.

Info

Publication number
NO883444L
NO883444L NO88883444A NO883444A NO883444L NO 883444 L NO883444 L NO 883444L NO 88883444 A NO88883444 A NO 88883444A NO 883444 A NO883444 A NO 883444A NO 883444 L NO883444 L NO 883444L
Authority
NO
Norway
Prior art keywords
procedure
preparation
amino acid
acid compounds
saturated amino
Prior art date
Application number
NO88883444A
Other languages
English (en)
Other versions
NO172495C (no
NO883444D0 (no
NO172495B (no
Inventor
Hans Allgeier
Christof Angst
Guido Bold
Rudolf Duthaler
Roland Heckendorn
Antonio Togni
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO883444D0 publication Critical patent/NO883444D0/no
Publication of NO883444L publication Critical patent/NO883444L/no
Publication of NO172495B publication Critical patent/NO172495B/no
Publication of NO172495C publication Critical patent/NO172495C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/16—Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165—Esters of thiophosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/48—Phosphonous acids [RP(OH)2] including [RHP(=O)(OH)]; Thiophosphonous acids including [RP(SH)2], [RHP(=S)(SH)]; Derivatives thereof
    • C07F9/4808—Phosphonous acids [RP(OH)2] including [RHP(=O)(OH)]; Thiophosphonous acids including [RP(SH)2], [RHP(=S)(SH)]; Derivatives thereof the acid moiety containing a substituent or structure which is considered as characteristic
    • C07F9/4825—Acyclic unsaturated acids or derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/302—Acyclic unsaturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3826—Acyclic unsaturated acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO88883444A 1987-08-04 1988-08-03 Fremgangsmaate for fremstilling av terapeutisk aktive, ikke-mettede aminosyreforbindelser NO172495C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH298687 1987-08-04

Publications (4)

Publication Number Publication Date
NO883444D0 NO883444D0 (no) 1988-08-03
NO883444L true NO883444L (no) 1989-02-06
NO172495B NO172495B (no) 1993-04-19
NO172495C NO172495C (no) 1993-07-28

Family

ID=4246086

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88883444A NO172495C (no) 1987-08-04 1988-08-03 Fremgangsmaate for fremstilling av terapeutisk aktive, ikke-mettede aminosyreforbindelser

Country Status (16)

Country Link
EP (1) EP0302826A3 (no)
JP (2) JP2714018B2 (no)
KR (1) KR970011164B1 (no)
AU (1) AU605340B2 (no)
CA (1) CA1328113C (no)
DD (1) DD282016A5 (no)
DK (1) DK434788A (no)
FI (1) FI94415C (no)
HU (1) HU202242B (no)
IL (1) IL87246A (no)
NO (1) NO172495C (no)
NZ (1) NZ225649A (no)
PH (1) PH27591A (no)
PT (1) PT88170B (no)
YU (1) YU150188A (no)
ZA (1) ZA885653B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175344A (en) * 1986-02-13 1992-12-29 Ciba-Geigy Corporation Unsaturated amino acids
DK0391850T3 (da) * 1989-04-07 1994-10-24 Ciba Geigy Ag Umættede aminodicarboxylsyrederivater
US5294734A (en) * 1989-09-26 1994-03-15 Ciba-Geigy Corp. 4-substituted 2-aminoalk-3-enoic acids
DE59009368D1 (de) * 1989-09-26 1995-08-10 Ciba Geigy Ag Phosphonsäure, Verfahren zur Herstellung und Verwendung als Arzneimittelwirkstoff.
US5488140A (en) * 1989-09-26 1996-01-30 Ciba-Geigy Corporation 4-substituted 2-aminoalk-3-enoic
US7414086B2 (en) 2005-05-13 2008-08-19 Shin-Etsu Chemical Co., Ltd. Room temperature-curable organopolysiloxane compositions
JP2009511624A (ja) * 2005-10-18 2009-03-19 サーントゥル ナシオナル ドゥ ラ ルシェルシュ シャーンティフィク （セ エン エール エス） 次亜リン酸誘導体及びその治療的用途
JP4952952B2 (ja) 2008-09-12 2012-06-13 信越化学工業株式会社 室温硬化性オルガノポリシロキサン組成物の製造方法
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE70535T1 (de) * 1986-02-13 1992-01-15 Ciba Geigy Ag Ungesaettigte aminosaeuren.

Also Published As

Publication number Publication date
YU150188A (en) 1990-04-30
PT88170A (pt) 1989-06-30
ZA885653B (en) 1989-04-26
FI883589A (fi) 1989-02-05
KR890003786A (ko) 1989-04-18
DD282016A5 (de) 1990-08-29
PT88170B (pt) 1995-03-01
JPH1053597A (ja) 1998-02-24
PH27591A (en) 1993-08-31
HUT47947A (en) 1989-04-28
DK434788A (da) 1989-02-05
IL87246A0 (en) 1989-03-31
EP0302826A2 (de) 1989-02-08
IL87246A (en) 1996-07-23
JP2714018B2 (ja) 1998-02-16
EP0302826A3 (de) 1991-04-03
FI94415C (fi) 1995-09-11
CA1328113C (en) 1994-03-29
FI883589A0 (fi) 1988-08-01
HU202242B (en) 1991-02-28
NO172495C (no) 1993-07-28
AU605340B2 (en) 1991-01-10
NO883444D0 (no) 1988-08-03
JPH0248586A (ja) 1990-02-19
NZ225649A (en) 1991-05-28
NO172495B (no) 1993-04-19
FI94415B (fi) 1995-05-31
AU2038988A (en) 1989-03-02
KR970011164B1 (ko) 1997-07-08
DK434788D0 (da) 1988-08-03

Similar Documents

Publication Publication Date Title
NO852025L (no) Fremgangsmaate til fremstilling av 7-amino-1-cyklopropyl-6,8-dihalogen-1,4-dihydro-4-okso-3-chinolinkarboksylsyre.
NO156940C (no) AnlogifremgangsmŸte til fremstilling av terapeutisk aktive cis, endo-2-azabicyklo-(3.3.0)-oktan-3-karboksylsyrer.
NO832701L (no) Fremgangsmaate til fremstilling av metylen-difosfonsyre-derivater.
NO166639C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner.
NO871879D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktive heterocykliske forbindelser.
NO165143C (no) Fremgangsmaate til fremstilling av hydrokloridet av fenyl-1-dietylaminokarbonyl-1-aminometyl-2-cyklopropan (z).
NO160444C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive imidazo-pyrazolo-pyrimidiner.
NO814424L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme 5,5`-azobis-salisylsyreforbindelser.
NO164168C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,7,4-triazolforbindelser.
NO895067D0 (no) Fremgangsmaate til fremstilling av derivater av alfa, d-glukofuranose.
NO880473D0 (no) Fremgangsmaate til fremstilling av substituerte 3,4-dihydro-2h-benzopyraner.
NO861486L (no) Fremgangsmaate til fremstilling av fluorerte benzyltriazolforbindelser.
NO883444L (no) Fremgangsmaate til fremstilling av nye, umettede aminosyreforbindelser.
NO880851D0 (no) Fremgangsmaate for fremstilling av nye renin-inhibitorer.
NO874888L (no) Fremgangsmaate til fremstilling av aminometyl-5,6,7,8-tetrahydronaftyloksyeddiksyrer.
NO863389D0 (no) Fremgangsmaate til fremstilling av substituerte toluidiner.
NO167807C (no) Analogifremgangsmaate til fremstilling av 3',4'-dinitrogensubstituerte epipodofyllotoksinglukosidderivater.
NO159080C (no) Fremgangsmaate til fremstilling av 2,4-diklor-5-fluor-benzosyre.
NO161064C (no) Analogifremgangsmaate til fremstilling av fenyl-nonatetraensyrederivater.
NO863343L (no) Fremgangsmaate for fremstilling av gem-dihalo-1,8-diamino-4-aza-octaner.
NO860273L (no) Fremgangsmaate for fremstilling av 4,4-dialkyl-2-azetidinoner.
NO882028L (no) Fremgangsmaate for fremstilling av cardiotone, tricykliskeimidazoloner.
NO891025D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktive sialosylglycerider.
NO874617D0 (no) Fremgangsmaate til fremstilling av 2,6-diamino-3-halogenobenzylpyridiner.
NO862910D0 (no) Fremgangsmaate for fremstilling av 3,7-disubstituerte 3-cefem-forbindelser.